This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.

Publisher: Bentham Science Publishers

Related content
Volume 8, Number 3, September 2008

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

Celiac Disease: Pathogenesis and Novel Therapeutic Strategies
pp. 152-158(7)
Authors: Baldassarre, Mariella; Laneve, Anna M.; Grosso, Roberto; Laforgia, Nicola

Favourites:Add to Favourites

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease
pp. 159-172(14)
Authors: Cabral, G. A.; Griffin-Thomas, L.

Favourites:Add to Favourites

Genome Study of Kidney Disease in the Age of Post Genome-Sequencing
pp. 173-183(11)
Authors: Doi, Kent; Okamoto, Koji; Tokunaga, Katsushi; Fujita, Toshiro; Noiri, Eisei

Favourites:Add to Favourites

Harnessing CD36 to Rein in Inflammation
pp. 184-191(8)
Authors: Parsons, M. S.; Barrett, L.; Little, C.; Grant, M. D.

Favourites:Add to Favourites

Trends in Metabolic Syndrome and Gene Networks in Human and Rodent Models
pp. 198-207(10)
Authors: Kraja, Aldi T.; Province, Michael A.; Huang, Pinchia; Jarvis, Joseph P.; Rice, Treva; Cheverud, James M.; Rao, D. C.

Favourites:Add to Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more